Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Blood|May 2, 2009
Hiding from ABT-737 in lymph nodesAnthony Letai
Cancer Cell|December 14, 2016
S63845, an MCL-1 Selective BH3 Mimetic: Another Arrow in Our QuiverAnthony Letai
The Journal of Clinical Investigation|October 4, 2005
Pharmacological manipulation of Bcl-2 family members to control cell deathAnthony Letai
Molecular Cell|March 18, 2006
Growth factor withdrawal and apoptosis: the middle gameAnthony Letai
Cell|June 11, 2021
Death in the Fas, ELANEAnthony Letai
The Journal of Cell Biology|April 22, 2009
Puma strikes BaxAnthony Letai
Cancer Cell|November 14, 2006
Restoring cancer's death sentenceAnthony Letai
Expert Opinion on Biological Therapy|March 29, 2003
BH3 domains as BCL-2 inhibitors: prototype cancer therapeuticsAnthony Letai
Nature Medicine|September 9, 2017
Functional precision cancer medicine-moving beyond pure genomicsAnthony Letai
Blood|March 12, 2011
A new face of BCL-2 inhibition in CLLAnthony Letai
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Blood|May 2, 2009
Hiding from ABT-737 in lymph nodesAnthony Letai
Cancer Cell|December 14, 2016
S63845, an MCL-1 Selective BH3 Mimetic: Another Arrow in Our QuiverAnthony Letai
The Journal of Clinical Investigation|October 4, 2005
Pharmacological manipulation of Bcl-2 family members to control cell deathAnthony Letai
Molecular Cell|March 18, 2006
Growth factor withdrawal and apoptosis: the middle gameAnthony Letai
Cell|June 11, 2021
Death in the Fas, ELANEAnthony Letai
The Journal of Cell Biology|April 22, 2009
Puma strikes BaxAnthony Letai
Cancer Cell|November 14, 2006
Restoring cancer's death sentenceAnthony Letai
Expert Opinion on Biological Therapy|March 29, 2003
BH3 domains as BCL-2 inhibitors: prototype cancer therapeuticsAnthony Letai
Nature Medicine|September 9, 2017
Functional precision cancer medicine-moving beyond pure genomicsAnthony Letai
Blood|March 12, 2011
A new face of BCL-2 inhibition in CLLAnthony Letai
Pageof 19